Literature DB >> 17395024

Alterations in myocardial metabolism in the diabetic myocardium.

Harold L Lazar1.   

Abstract

Free fatty acids are the preferred substrate for the myocardium. However, under conditions of ischemia, glucose becomes the primary myocardial energy source. Its metabolism avoids the toxic end-products of free fatty acids, which include oxygen free radicals. Patients with diabetes mellitus have impaired uptake of glucose. As a consequence the diabetic myocardium relies heavily on free fatty acid metabolism as its energy source. The results of these alterations in myocardial metabolism ultimately contribute to changes in endothelial function, inflammation, and oxidative stress. This review describes the defects in diabetic myocardial metabolism and how they contribute to cardiovascular dysfunction. The mechanisms by which intravenous insulin infusions can be used to modulate these changes in myocardial metabolism to improve clinical outcomes are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17395024     DOI: 10.1053/j.semtcvs.2006.12.006

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  4 in total

Review 1.  Mechanisms underlying the impaired contractility of diabetic cardiomyopathy.

Authors:  Marie-Louise Ward; David J Crossman
Journal:  World J Cardiol       Date:  2014-07-26

Review 2.  Perioperative control of blood glucose level in cardiac surgery.

Authors:  Kenji Minakata; Ryuzo Sakata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-01-05

3.  Proteomic analysis in diabetic cardiomyopathy using bioinformatics approach.

Authors:  Allam Appa Rao; Hanuman Thota; Ramamurthy Adapala; Suresh Babu Changalasetty; Ramachandra Sridhar Gumpeny; Annapurna Akula; Lalitha Saroja Thota; Siva Reddy Challa; M R Narasinga Rao; Undurti N Das
Journal:  Bioinform Biol Insights       Date:  2008-01-21

4.  Assessing oral glucose and intravenous insulin loading protocol in 18F-fluorodeoxyglucose positron emission tomography cardiac viability studies.

Authors:  Ismet Sarikaya; Prem N Sharma; Ali Sarikaya; Abdelhamid H Elgazzar
Journal:  World J Nucl Med       Date:  2020-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.